Morgan E Diolaiti

16PUBLICATIONS
129CO-AUTHORS
Molecular targetsBiomolecular modelling and designBiologically active moleculesPredictive and prognostic markersGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Aug 14, 2026
Publisher Correction: Targeting cancer-specific mutations with RNA-triggered chromatin shredding.

|Jun 08, 2026
Targeting cancer-specific mutations with RNA-triggered chromatin shredding.

|Jan 09, 2026
Large scale prospective evaluation of co-folding across 557 Mac1-ligand complexes and three virtual screens.

Jongbin Kim, Galen J Correy, Brendan W Hall

|Dec 17, 2025
Discovery of AVI-6451, a Potent and Selective Inhibitor of the SARS-CoV-2 ADP-Ribosylhydrolase Mac1 with Oral Efficacy In Vivo.

Priyadarshini Jaishankar, Galen J Correy, Yusuke Matsui

|Nov 26, 2025
Identification of a Two-Gene Biomarker Correlated with Sensitivity to Combined PARP7 Inhibition and AHR Activation in Cancer Cells.

Xuxu Gou, Huadong Chen, Morgan E Diolaiti

|Nov 19, 2025
The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2.

Rahul K Suryawanshi, Priyadarshini Jaishankar, Galen J Correy

Pageof 3

Frequent Collaborators

14 joint publications

Alan Ashworth

7 joint publications

Patrick O'Leary

7 joint publications

Nevan J Krogan

7 joint publications

James S Fraser